Navigation Links
Formedix CEO Invited to Speak at OpenClinica Global Conference in Boston
Date:6/14/2013

Burlington, MA (PRWEB) June 14, 2013

The OpenClinica Global Conference is being held in the Sheraton Hotel, Boston, MA this year with Formedix CEO, Mark Wheeldon presenting as part of a packed program of valuable sessions, offering attendees a deeper insight into the future developments at OpenClinica and how they are working with partners, such as Formedix to develop innovative solutions.

The conference program will offer delegates the opportunity to learn all about OpenClinica, hear real-life case studies and discover more about best practices in clinical trials. There will also be sessions aimed at previewing future developments at OpenClinica, such as the new partnership with Formedix. Mark Wheeldon’s presentation ‘Utilizing CDISC Standards to Drive Efficiencies in Study Set-up and Build with OpenClinica’ will discuss real life experiences of using CDISC Database Standards (Operational Data Model) to drive efficiencies in study set-up and study build. He will also discuss how the partnership with OpenClinica and the new solution, Transform for OpenClinica will help to further achieve reductions in study build times.

Formedix, the clinical trial automation software and consultancy services provider, will be further extending its family of integration and publishing products with the addition of Transform for OpenClinica. Transform for OpenClinica, to be released later this quarter, is a new integration with Formedix Universal Design Tool, Origin, which merges study specification and EDC build into one process to drastically cut OpenClinica build times, in some cases by more than 55%.

Mark Wheeldon, CEO of Formedix and lifelong advocate of vendor agnostic tools, says “I am delighted to be invited to present at this year’s OpenClinica conference and even more so to be able to pr
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. "Collaborate to Innovate" with Formedix at DIA Annual Meeting 2012
2. Formedix Partners with Perceptive Informatics for Forthcoming Webcast, “Four Secrets to Using CDISC Standards to Enable Clinical Trial Efficiencies”
3. Formedix to Host Webinar: Discover Define-XML - Practical Uses Today and a Technical Deep Dive on March 14, 2013
4. Formedix and OmniComm Partner to Offer CRO and Sponsors Multi-Vendor EDC Capabilities
5. Formedix to Host Executive Breakfast prior to Bay Area CDISC Network Meeting, May 23, 2013
6. Take a Standards Health Check with Formedix at DIA 49th Annual Meeting
7. Senior Management of NeoStem and Its Subsidiaries Invited to Speak at Seventh International Conference on Cell Therapy for Cardiovascular Disease
8. VBI’s Dr. Szczepan Baran is an Invited Speaker at the Swiss Laboratory Animal (SGV) National Meeting
9. P&P Optica Invited to Cambridge Innovation Centre for the Canadian Technology Accelerator Program, One of Eight Canadian Life Science Companies Chosen to Participate
10. Synteract Director of IT Services Toby Odenheim Speaking at March 2012 Outsourcing in Clinical Trials East Coast Conference
11. Luminex Corporation to Speak at Joint Department of Defense and Environmental Protection Agency 5th National Bio-Threat Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... , Mar. 05, 2015 Research and Markets ... the "Mature Biotech Outlook 2015: New Therapy Ventures ... offering. All biotech companies - Gilead ... in past year, have given a positive return and ... have been able to select therapy/niche indication where the ...
(Date:3/4/2015)... PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ) today ... , 3.75% Convertible Senior Notes due May 1, 2015 (May ... principal amount or approximately $5.72 per share, effective March 3, 2015. ... adjusted in connection with the regular quarterly dividend of $0.15 ... own shares of PDL on March 5, 2015, the record date. ...
(Date:3/4/2015)... , Mar. 04, 2015 Research and ... the addition of Jain PharmaBiotech,s new report ... their offering. This report follows ... characteristic that can be objectively measured and evaluated ... processes as well as pharmacological responses to a ...
(Date:3/4/2015)... , March 4, 2015 AcelRx Pharmaceuticals, ... pharmaceutical company focused on the development and commercialization ... and breakthrough pain, today announced that it will ... after market close on Monday, March 9th, 2015. ... at 4:30 p.m. Eastern Time (1:30 p.m. Pacific ...
Breaking Biology Technology:Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success 2Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success 3PDL BioPharma Announces Conversion Rate Adjustment for Convertible Note 2Global Biomarkers Report 2014-2024 - Technologies, Markets and Companies 2Global Biomarkers Report 2014-2024 - Technologies, Markets and Companies 3AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015 2AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015 3
... Engineering Physics at Stevens Institute of Technology, has been ... prestigious CAREER Award. One of the most competitive programs ... career development of faculty in the sciences who are ... awards provide a financial stipend to support research activity ...
... Technologies, Inc., a gene-centric life sciences company, releases ... protein with superior biological activity. MTOR ... growth, cell proliferation, cell motility, cell survival, protein ... desirable in high throughput functional screening assays and ...
... Reportlinker.com announces that a new market research ... Amphotericin B - Comprehensive patent search ... Eliminate unnecessary risk with the industry benchmark in ... a regularly updated, professional patent search performed by ...
Cached Biology Technology:Dr. Stefan Strauf of physics at Stevens receives NSF CAREER Award for quantum research 2Dr. Stefan Strauf of physics at Stevens receives NSF CAREER Award for quantum research 3OriGene Releases Bioactive Full-length Human MTOR Protein 2Reportlinker Adds Amphotericin B - Comprehensive patent search 2Reportlinker Adds Amphotericin B - Comprehensive patent search 3Reportlinker Adds Amphotericin B - Comprehensive patent search 4
(Date:2/5/2015)... -- New Market Research Reports Title Global ... 2020 has Been Added to GrandViewReseach.com Report Database ... reach USD 5.10 billion by 2020, according to a ... help identify the site of tissue damage in case ... in medical imaging applications. They have been extensively used ...
(Date:2/5/2015)... , Jan. 30, 2015  It is gratifying to ... and potential for genomic science as a means to ... prevention and treatment.  I was honored to participate in ... precision medicine program. Since the 1980s ... of genomics—from the first sequenced genome of a free ...
(Date:1/22/2015)... S.A. ("Company") (BM&FBOVESPA: VLID3 ON), is pleased to inform its ... of Washington,s Department of Licensing, in the United ... system for driver,s licenses and identification cards to its subsidiary, ... will start in January 2015, with enrollment and card production ...
Breaking Biology News(10 mins):IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2Valid USA Signs Contract For Washington Driver's License Issuance 2
... common molecular denominator in aging and many age-related diseases is ... PhD, HMS associate professor of pathology. The skin of a ... and in some ways that is a good metaphor for ... other types of cells over time. , Humans and other ...
... to developing the eye cancer retinoblastoma than mice because, ... activity of a gene critical to normal retinal development ... at St. Jude Children's Research Hospital. The study, published ... why humans with a defective copy of the Retinoblastoma ...
... given extra shots of the plant steroid brassinolide, plants ... steroids. Tracing brassinolide's signal deep into the cell's nucleus, ... unraveled how the growth-boosting hormone accomplishes its job at ... by Joanne Chory, a professor in the Plant Molecular ...
Cached Biology News:Free radical cell death switch identified 2Ozone recovering, but unlikely to stabilize at pre-1980 levels, says study 2Ozone recovering, but unlikely to stabilize at pre-1980 levels, says study 3
Rabbit polyclonal to Quinaldic Acid ( Abpromise for all tested applications). Antigen: Synthetic peptide Quinaldic Acid conjugated to a protein carrier....
... c-Jun N-terminal kinase (JNK) is one of ... luciferase has been used as a sensitive ... Luciferase provides a 1000-fold increase in sensitivity ... (CAT) assay. Firefly luciferase catalyzes the oxidative ...
... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. ID clarifier: ...
... This CLS number is a ... easily match Cornings product number. ... please order under the old ... customer service for assistance. ID ...
Biology Products: